Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.42K Hold
80
﹤0.01% 502
2025
Q4
$3.92K Hold
80
﹤0.01% 533
2025
Q3
$3.45K Hold
80
﹤0.01% 540
2025
Q2
$2.97K Buy
+80
New +$3.06K ﹤0.01% 508
2024
Q1
Sell
-18
Closed -$667 712
2023
Q4
$667 Sell
18
-58
-76% -$2.08K ﹤0.01% 661
2023
Q3
$2.75K Buy
76
+23
+43% +$816 ﹤0.01% 608
2023
Q2
$1.89K Buy
+53
New +$1.9K ﹤0.01% 660
2022
Q4
Sell
-320
Closed -$9K 635
2022
Q3
$9K Buy
+320
New +$12.1K ﹤0.01% 516
2021
Q3
Sell
-35
Closed -$2K 623
2021
Q2
$2K Hold
35
﹤0.01% 602
2021
Q1
$2K Sell
35
-45
-56% -$2.04K ﹤0.01% 552
2020
Q4
$4K Buy
+80
New +$3.67K ﹤0.01% 606
2019
Q4
Sell
-248
Closed -$13K 540
2019
Q3
$13K Hold
248
﹤0.01% 411
2019
Q2
$12K Sell
248
-638
-72% -$32K ﹤0.01% 582
2019
Q1
$46K Buy
886
+638
+257% +$31.9K ﹤0.01% 332
2018
Q4
$12K Hold
248
﹤0.01% 437
2018
Q3
$12K Buy
+248
New +$12.6K ﹤0.01% 464
2017
Q3
Sell
-800
Closed -$43K 578
2017
Q2
$43K Hold
800
﹤0.01% 335
2017
Q1
$42K Sell
800
-142
-15% -$7.2K ﹤0.01% 327
2016
Q4
$45K Sell
942
-250
-21% -$12.3K 0.01% 314
2016
Q3
$64K Buy
1,192
+250
+27% +$13.7K 0.01% 277
2016
Q2
$51K Hold
942
0.01% 274
2016
Q1
$48K Buy
942
+142
+18% +$7.07K 0.01% 275
2015
Q4
$40K Hold
800
﹤0.01% 281
2015
Q3
$38K Sell
800
-51,014
-98% -$2.66M ﹤0.01% 296
2015
Q2
$2.7M Buy
51,814
+2,919
+6% +$164K 0.31% 104
2015
Q1
$2.82M Buy
48,895
+244
+0.5% +$14K 0.32% 99
2014
Q4
$2.6M Sell
48,651
-1,449
-3% -$81.1K 0.28% 109
2014
Q3
$2.88M Buy
50,100
+3,988
+9% +$244K 0.3% 110
2014
Q2
$3.08M Buy
46,112
+4,631
+11% +$313K 0.34% 103
2014
Q1
$2.77M Buy
41,481
+338
+0.8% +$22.9K 0.32% 104
2013
Q4
$2.75M Buy
41,143
+2,583
+7% +$167K 0.32% 104
2013
Q3
$2.42M Buy
38,560
+3,314
+9% +$213K 0.3% 109
2013
Q2
$2.2M Buy
+35,246
New +$2.24M 0.28% 108

Other funds holding GSK

MOTCO's GSK Position: Q1 2026 in Review

MOTCO held its GSK (GSK) position steady in Q1 2026 at 80 shares worth $4.42K. The position accounts for ﹤0.01% of the portfolio, ranked #502.

MOTCO first reported a position in GSK in Q2 2013 and has held it in 33 quarters since. The position peaked at $3.08M in Q2 2014. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • MOTCO held 80 shares of GSK worth $4.42K as of Q1 2026.
  • MOTCO left its GSK share count unchanged in Q1 2026.
  • GSK made up ﹤0.01% of MOTCO's portfolio in Q1 2026, its #502 holding.
  • MOTCO first reported a position in GSK in Q2 2013 and has held it in 33 quarters since.
  • MOTCO's GSK position peaked at $3.08M in Q2 2014.
  • 1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on MOTCO's 13F filing for Q1 2026, filed 22 Apr 2026.